Drug OKd for brain disorder
From Times Wire Services
The first U.S. treatment to reduce involuntary movements caused by Huntington’s disease, a genetic brain disorder, was approved by the Food and Drug Administration.
The FDA cleared Xenazine, a tablet made by closely held Prestwick Pharmaceuticals Inc.
